BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9872053)

  • 1. Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends.
    Ancelin K; Brun C; Gilson E
    Bioessays; 1998 Nov; 20(11):879-83. PubMed ID: 9872053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E
    Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of TRF2 with model telomeric ends.
    Khan SJ; Yanez G; Seldeen K; Wang H; Lindsay SM; Fletcher TM
    Biochem Biophys Res Commun; 2007 Nov; 363(1):44-50. PubMed ID: 17850765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human interstitial telomere associates in vivo with specific TRF2 and TIN2 proteins.
    Mignon-Ravix C; Depetris D; Delobel B; Croquette MF; Mattei MG
    Eur J Hum Genet; 2002 Feb; 10(2):107-12. PubMed ID: 11938440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms.
    Wu Y; Mitchell TR; Zhu XD
    Mech Ageing Dev; 2008 Oct; 129(10):602-10. PubMed ID: 18812185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomeres: more than chromosomal non-sticking ends.
    Kierszenbaum AL
    Mol Reprod Dev; 2000 Sep; 57(1):2-3. PubMed ID: 10954850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeric localization of TRF2, a novel human telobox protein.
    Bilaud T; Brun C; Ancelin K; Koering CE; Laroche T; Gilson E
    Nat Genet; 1997 Oct; 17(2):236-9. PubMed ID: 9326951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA structure-dependent recruitment of telomeric proteins to single-stranded/double-stranded DNA junctions.
    Yanez GH; Khan SJ; Locovei AM; Pedroso IM; Fletcher TM
    Biochem Biophys Res Commun; 2005 Mar; 328(1):49-56. PubMed ID: 15670749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.
    Wu Y; Zacal NJ; Rainbow AJ; Zhu XD
    DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence induced by altered telomere state, not telomere loss.
    Karlseder J; Smogorzewska A; de Lange T
    Science; 2002 Mar; 295(5564):2446-9. PubMed ID: 11923537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A RAP1/TRF2 complex inhibits nonhomologous end-joining at human telomeric DNA ends.
    Bae NS; Baumann P
    Mol Cell; 2007 May; 26(3):323-34. PubMed ID: 17499040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes.
    Zhu XD; Niedernhofer L; Kuster B; Mann M; Hoeijmakers JH; de Lange T
    Mol Cell; 2003 Dec; 12(6):1489-98. PubMed ID: 14690602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells.
    Tahara H; Shin-Ya K; Seimiya H; Yamada H; Tsuruo T; Ide T
    Oncogene; 2006 Mar; 25(13):1955-66. PubMed ID: 16302000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
    Arkus N
    J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeric 3'-overhang length is associated with the size of telomeres.
    Rahman R; Forsyth NR; Cui W
    Exp Gerontol; 2008 Apr; 43(4):258-65. PubMed ID: 18280685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRF2 protects human telomeres from end-to-end fusions.
    van Steensel B; Smogorzewska A; de Lange T
    Cell; 1998 Feb; 92(3):401-13. PubMed ID: 9476899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.
    Gomez D; O'Donohue MF; Wenner T; Douarre C; Macadré J; Koebel P; Giraud-Panis MJ; Kaplan H; Kolkes A; Shin-ya K; Riou JF
    Cancer Res; 2006 Jul; 66(14):6908-12. PubMed ID: 16849533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer.
    Muñoz P; Blanco R; Flores JM; Blasco MA
    Nat Genet; 2005 Oct; 37(10):1063-71. PubMed ID: 16142233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation of telomeres length: making the telomeres accessible?].
    Riou JF; Gomez D; Mergny JL; Guittat L; Paterski R; Chenais B; Morjani H; Trentesaux C
    Bull Cancer; 2005 Jan; 92(1):13-22. PubMed ID: 15811846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2.
    Opresko PL; Fan J; Danzy S; Wilson DM; Bohr VA
    Nucleic Acids Res; 2005; 33(4):1230-9. PubMed ID: 15731343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.